Fidelis Capital Partners LLC Grows Position in Colgate-Palmolive (NYSE:CL)

Fidelis Capital Partners LLC raised its stake in Colgate-Palmolive (NYSE:CL) by 9.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,171 shares of the company’s stock after purchasing an additional 1,359 shares during the period. Fidelis Capital Partners LLC’s holdings in Colgate-Palmolive were worth $1,320,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in CL. Swedbank AB lifted its holdings in Colgate-Palmolive by 1.4% in the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares during the period. Stephens Inc. AR increased its position in Colgate-Palmolive by 2.1% during the 3rd quarter. Stephens Inc. AR now owns 11,951 shares of the company’s stock worth $1,241,000 after purchasing an additional 251 shares in the last quarter. Creative Financial Designs Inc. ADV increased its position in Colgate-Palmolive by 142.1% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 869 shares of the company’s stock worth $90,000 after purchasing an additional 510 shares in the last quarter. Gladstone Institutional Advisory LLC boosted its stake in Colgate-Palmolive by 10.3% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 6,758 shares of the company’s stock worth $702,000 after buying an additional 631 shares during the last quarter. Finally, Chicago Partners Investment Group LLC boosted its stake in Colgate-Palmolive by 10.0% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 5,809 shares of the company’s stock worth $575,000 after buying an additional 527 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on CL. Barclays reduced their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Stifel Nicolaus lowered their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. UBS Group lowered their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Finally, StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.61.

Colgate-Palmolive Stock Up 1.7 %

NYSE:CL opened at $92.74 on Tuesday. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a 50-day simple moving average of $88.76 and a 200 day simple moving average of $95.37. The company has a market cap of $75.26 billion, a PE ratio of 26.35, a PEG ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the company posted $0.87 earnings per share. On average, sell-side analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.16%. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.